top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (TSX:RY)

220.14 -2.81 (-1.26%)
Streaming Delayed Price Updated: 12:23 PM EDT, Mar 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
39 40 Next >
News headline image
RBC Analyst Sees Growth Potential In TD Synnex Despite Short-Term Margin Pressures ↗
RBC Capital Markets analyst David Paige reiterated an Outperform rating on TD Synnex and maintained a $145 price forecast. 
Via Benzinga
News headline image
BlackBerry Stock Jumps After Wall Street Hikes Price Targets, But Remains Cautious: Retail’s Exuberant ↗
Analysts are cautiously optimistic on BlackBerry, citing stronger pipeline visibility with QNX and IoT viewed as key growth drivers after its Q1 earnings beat estimates. 
Via Stocktwits
Topics Earnings
News headline image
3 Skyrocketing Artificial Intelligence (AI) Stocks That Can Plummet 71% to 80%, According to Select Wall Street Analysts ↗
Today's high-octane AI stocks could be some of the worst performers over the next year, based on the forecasts of select analysts. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering ↗
The offering is being led by J.P. Morgan, Morgan Stanley, Guggenheim Securities, and Cantor. 
Via Stocktwits
News headline image
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug ↗
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug. 
Via Investor's Business Daily
News headline image
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial ↗
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said. 
Via Stocktwits
News headline image
CarMax Beat Expectations, But Here's What Could Still Hold It Back ↗
RBC maintains Outperform rating on CarMax, raises price target to $81. Q1 earnings beat estimates with strong sales growth, market share gains, and cost management efforts. 
Via Benzinga
Topics Earnings
News headline image
Melissa Sanasie Champions Data Literacy and Storytelling in Marketing
Via Get News
News headline image
Cidara Launches 93% As A Universal Flu Shot Becomes A Closer Reality ↗
The midstage study hit all its goals, representing a "best case" scenario, according to one analyst. 
Via Investor's Business Daily
News headline image
Circle, GMS Stocks See Big Jump Friday Morning – Here’s What Wall Street Analysts Are Saying ↗
While many analysts on Wall Street have raised their price targets on GMS after The Wall Street Journal’s report that Home Depot may have submitted a competing bid against QXO, RBC Capital said the... 
Via Stocktwits
News headline image
$1000 Invested In RBC Bearings 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
InvestorNewsBreaks – Aegis Capital Corp. Announces Completion of $4.3 Million Public Offering for Stardust Power (NASDAQ: SDST)
Via Investor Brand Network
Topics Retirement
News headline image
Should You Forget Nvidia and Buy This Artificial Intelligence (AI) Stock Right Now? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Wall Street Turns Bullish On Hinge Health As Analysts Laud Profitable Growth, AI Disruption In MSK Care ↗
Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
RBC BEARINGS INC (NYSE:RBC) – A Quality Stock with Strong Fundamentals ↗
RBC Bearings (NYSE:RBC) meets quality investing criteria with strong ROIC, EBIT growth, and profit quality, though its valuation remains high. A deeper look for long-term investors. 
Via Chartmill
News headline image
Adobe Stock Slides as AI Optimism Reportedly Fades, But Retail Remains Defiantly Bullish ↗
Investors are growing cautious about the timeline and payoff of Adobe’s AI initiatives, despite the company beating Q2 estimates and raising its full-year revenue forecast. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Air India Crash Prompts Boeing Top Execs, Including CEO Ortberg, To Cancel Paris Air Show Visit ↗
The Paris Air Show, which begins Monday, is the aviation industry’s largest trade show and typically sees several deals between aircraft manufacturers and airlines. 
Via Stocktwits
News headline image
A Glimpse Into The Expert Outlook On RBC Bearings Through 4 Analysts ↗
 
Via Benzinga
News headline image
Snowflake Rival Databricks Touts Torrid Revenue Growth Rate Amid AI Boom ↗
Snowflake stock has been pressured by views that Databricks is gaining market share as companies develop artificial intelligence applications. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Will the Stock Market Keep Soaring in 2025? Wall Street Analysts Are Changing Their Forecasts. ↗
Via The Motley Fool
Topics Economy Government World Trade
News headline image
What's Going On With Starbucks Stock Wednesday? ↗
Starbucks Corporation (NASDAQ:SBUX) shares are moving higher on Wednesday. Analysts at RBC Capital and TD Securities weighed in on the stock. Here's what you need to know. 
Via Benzinga
News headline image
US FDA Places Clinical Hold On Gilead Trials Of Two Investigational HIV Treatments: Retail’s On The Fence ↗
The clinical hold is due to the identification of a safety signal, characterized by decreases in CD4+ T-cell (CD4) and absolute lymphocyte counts, in certain participants receiving the combination of... 
Via Stocktwits
News headline image
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia ↗
Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment. 
Via Investor's Business Daily
News headline image
2 Unpopular Stocks that Deserve a Second Chance and 1 to Brush Off
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
TechMediaBreaks – Aegis Capital Corp. Leads $1.25 Million Underwritten Public Offering for Cemtrex (NASDAQ: CETX)
Via Investor Brand Network
Topics Retirement
News headline image
Insurance Software Maker Guidewire Pops On Earnings Report. Asana Plunges. ↗
Guidewire stock rallied after the insurance software company reported a sharp gain in quarterly adjusted earnings. 
Via Investor's Business Daily
CryptoNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Adopts Bitcoin Treasury Strategy to Strengthen Financial and Market Position
Via CryptoCurrencyWire
Topics Economy
CryptoNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Adopts Bitcoin Treasury Strategy to Strengthen Financial and Market Position
Via Investor Brand Network
Topics Economy
News headline image
MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover ↗
The deal is being discussed ahead of key data from MoonLake in patients with a skin disease. 
Via Investor's Business Daily
News headline image
GE Aerospace Teams Up With Kratos To Develop Engines For Next-Gen UAVs And CCA-Type Aircraft ↗
Under the new agreement, the companies will jointly develop, manufacture, and test the GEK800 engine and begin work on a second engine, the GEK1500. 
Via Stocktwits
Topics Artificial Intelligence
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page